Search
Citações e referências (10)
Thermo Scientific™
Samco™ Graduated Transfer Pipettes
Measure more than one volume accurately by using these graduated polyethylene transfer pipettes. Built-in pipette bulb eliminates need for plugging, packaging, and autoclaving.
Have Questions?
Alterar visualização
| Número do catálogo | Volume (Metric) | Sterility | Graduations | Packaging Type |
|---|---|---|---|---|
| 225 | 7.7 mL | Non-sterile | 1, 2, 3 mL | Bulk 500/Pk 10Pk/Cs 5000/Cs |
| 212 | 3.9 mL | Non-sterile | 0.25, 0.50, 0.75, 1 mL | Bulk 500/Pk 10Pk/Cs 5000/Cs |
| 212-1S | 3.9 mL | Sterile | 0.25, 0.50, 0.75, 1 mL | Individually Wrapped 500/Pk 8Pk/Cs 4000/Cs |
| 222 | 5.8 mL | Non-sterile | 0.25, 0.50, 0.75, 1 mL | Bulk 500/Pk 10Pk/Cs 5000/Cs |
| 274-1S | 4.6 mL | Sterile | 0.5, 1, 1.5, 2 mL | Individually Wrapped 500/Pk 8Pk/Cs 4000/Cs |
| 222-10S | 5.8 mL | Sterile | 0.25, 0.50, 0.75, 1 mL | 10/Bag, 500/Pk. |
| 212NL | 3.9 mL | Non-sterile | 0.25, 0.50, 0.75, 1 mL | |
| 222NL | 5.8 mL | Non-sterile | 0.25, 0.50, 0.75, 1 mL | |
| 222NL-10S | 5.8 mL | Sterile | 0.25, 0.50, 0.75, 1 mL | 10/Bag, 500/Pack |
| 222NL-1S | 5.8 mL | Sterile | 0.25, 0.50, 0.75, 1 mL | Individually Wrapped, 500/pk |
| 222NL-20S | 5.8 mL | Sterile | 0.25, 0.50, 0.75, 1 mL | 20/Bag, 500/Pk. |
| 225NL | 7.5 mL | Non-sterile | 0.5, 1.0, 1.5, 2.0, 2.5, 3.0 mL | |
| 225NL-1S | 7.5 mL | Sterile | 0.5, 1.0, 1.5, 2.0, 2.5, 3.0 mL | Individually Wrapped, 500/pk |
| 282NL | 1.5 mL | Non-sterile | 0.1 , 0.2, 0.3 mL | |
| 212-20S | 3.9 mL | Sterile | 0.25, 0.50, 0.75, 1 mL | 20/Bag, 500/Pk., 4000/Cs. |
| 222-20S | 5.8 mL | Sterile | 0.25, 0.50, 0.75, 1 mL | 20/Bag, 500/Pk., 4000/Cs. |
| 225-1S | 7.7 mL | Sterile | 1, 2, 3 mL | Individually Wrapped 500/Pk 8Pk/Cs 4000/Cs |
| 225-20S | 7.7 mL | Sterile | 1, 2, 3 mL | 20/Bag, 500/Pk., 4000/Cs. |
| 274 | 4.6 mL | Non-sterile | 0.5, 1, 1.5, 2 mL | Bulk 500/Pk 10Pk/Cs 5000/Cs |
| 274-20S | 4.6 mL | Sterile | 0.5, 1, 1.5, 2 mL | 20/Bag, 500/Pk., 4000/Cs. |
| 282-1S | 1.5 mL | Sterile | 0.1, 0.2, 0.3 mL | Individually Wrapped 500/Pk 8Pk/Cs 4000/Cs |
| 282-20S | 1.5 mL | Sterile | 0.1, 0.2, 0.3 mL | 20/Bag, 500/Pk., 4000/Cs. |
| 718TS conhecido também como 718 | 5.8 mL | Non-sterile | 0.25, 0.5, 0.75, 1 mL | Bulk 500/Pk 10Pk/Cs 5000/Cs |
| 728NL | 13.7 mL | Non-sterile | 1, 2, 3, 4, 5 mL | Bulk 250/Pk 10Pk/Cs 2500/Cs |
| 222-1S | 5.8 mL | Sterile | 0.25, 0.5, 0.75, 1 mL | |
| 728NL-20S | 13.7 mL | Sterile | 1, 2, 3, 4, 5 mL | 20/Bag, 12 Bags/PK, 8 PK per CS, 1,920 per CS |
Número do catálogo 225
Preço (BRL)Requisite uma Cotação
-
Volume (Metric):
7.7 mL
Sterility:
Non-sterile
Graduations:
1, 2, 3 mL
Packaging Type:
Bulk 500/Pk 10Pk/Cs 5000/Cs
Accurately measure more than one volume by using Thermo Scientific™ Samco™ Graduated Transfer Pipettes. Single-unit design features a built-in pipette bulb that eliminates need for plugging, packaging, and autoclaving while preventing cross-contamination.
- Made of shatterproof, nontoxic polyethylene
- Low-affinity surface prevents proteins binding in research applications
- Can be frozen in liquid nitrogen, or heat sealed for storage
Especificações
Bulb Draw (Metric)3.2 mL
DescriptionTransfer Pipette, Large Bulb, Graduated to 1mL, 2mL, 3mL
Diameter (Metric) Outer7.9 mm
Drops/mL21
GraduatedYes
Graduations1, 2, 3 mL
Packaging TypeBulk 500/Pk 10Pk/Cs 5000/Cs
DisposableSingle-use
Length (Metric)15.5 cm
MaterialLDPE
SterilityNon-sterile
TypeGraduated Transfer Pipet
Volume (Metric)7.7 mL
Unit SizePAC
Citações e referências (10)
Citações e referências
Abstract
Characterization of the SIM-A9 cell line as a model of activated microglia in the context of neuropathic pain.
Journal:PLoS One
PubMed ID:32287325
'Resident microglia of the central nervous system are being increasingly recognized as key players in diseases such as neuropathic pain. Biochemical and behavioral studies in neuropathic pain rodent models have documented compelling evidence of the critical role of ATP mediated-P2X4R-brain-derived neurotrophic factor (BDNF) signaling pathway in the initiation and maintenance
Expression of the neonatal Fc-receptor in placental-fetal endothelium and in cells of the placental immune system.
Journal:Placenta
PubMed ID:30955709
'Starting from the second trimester of pregnancy, passive immunity is provided to the human fetus by transplacental transfer of maternal IgG. IgG transfer depends on the neonatal Fc receptor, FcRn. While FcRn localization in the placental syncytiotrophoblast (STB) has been demonstrated unequivocally, FcRn expression in placental-fetal endothelial cells (pFECs), which
Sleep-restriction Inhibits Neurogenesis Through Decreasing the Infiltration of CD169
Journal:Neuroscience
PubMed ID:32081723
'Chronic sleep-restriction (SR) is shown to be correlated with neurodevelopmental disorders. However, the effects of SR during stroke recovery on neurorepair remain unclear. In this study, mice were subjected to 60?min of cerebral ischemia followed by reperfusion. The SR protocol was accomplished by depriving mice of sleep for 20?h/day for
CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons.
Journal:Neuron
PubMed ID:31422865
CRISPR/Cas9-based functional genomics have transformed our ability to elucidate mammalian cell biology. However, most previous CRISPR-based screens were conducted in cancer cell lines rather than healthy, differentiated cells. Here, we describe a CRISPR interference (CRISPRi)-based platform for genetic screens in human neurons derived from induced pluripotent stem cells (iPSCs). We
The WNT/ß-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro.
Journal:Sci Rep
PubMed ID:30886380
Upregulated Wnt/ß-catenin signaling is associated with increased cancer cell resistance and cancer cell-elicited immunosuppression. In non-neoplastic immune cells, upregulated Wnt/ß-catenin is, however, associated with either immunosuppression or immunostimulation. Therefore, it is difficult to predict the therapeutic impact inhibitors of Wnt/ß-catenin signaling will have when combined with cancer immunotherapy. Here, we